Table 1.
Patient characteristics (N = 64; female n = 30 [47%])
| M | SD | Min. | Max. | N (%) | |
|---|---|---|---|---|---|
| Age | 81 | 6.2 | 67 | 95 | 64 |
| Body mass index [kg/m2] | 25.6 | 4.1 | 18 | 34 | 64 |
| Diagnosis | |||||
| Alzheimer's disease dementia | 17 (27) | ||||
| Vascular dementia | 10 (16) | ||||
| Dementia, mixed type | 34 (53) | ||||
| Parkinson's disease dementia | 2 (3) | ||||
| Lewy‐body dementia | 1 (1) | ||||
| Mini‐mental status examination | 18.6 | 5.5 | 7 | 27 | 64 |
| Demtect | 4.2 | 1.6 | 1 | 6 | 58 |
| Clock‐drawing test | 5.0 | 3.4 | 0 | 14 | 57 |
| Neuropsychiatric inventory (NPI) | 19.2 | 12.2 | 0 | 51 | 64 |
| Cohen‐Mansfield agitation inventory (CMAI) | 49.1 | 12.0 | 29 | 83 | 64 |
| Cognitive reserve capacity, years of education | 11.9 | 2.6 | 7 | 18 | 63 |
| Bayer‐activities of daily living | 7.7 | 1.6 | 2.3 | 9.7 | 64 |
| Timed up and go test [s] | 14.4 | 5.2 | 7.3 | 32.9 | 64 |
| 10 meter gait speed [m/s] | 0.8 | 0.2 | 0.3 | 1.6 | 64 |
| Benzodiazepine dose (DED) [mg/day] | 4.0 | 1.9 | 0.3 | 7.5 | 10 (16) |
| Antipsychotic dose [mg/day] | 2.2 | 1.4 | 0.3 | 5.7 | 48 (75) |
| Antipsychotics only | 39 (61) | ||||
| Only benzodiazepines | 1 (2) | ||||
| Benzodiazepines and antipsychotics | 9 (14) | ||||
| No benzodiazepines or antipsychotics | 15 (23) | ||||
M = mean; SD = standard deviation; Min. = minimum; Max. = maximum; Range and scaling of psychopathometric instruments: NPI: 0‐144 points (0 meaning no symptoms); CMAI: 29‐203 points (29 meaning no symptoms); DED = Diazepam equivalent dose; OED = Olanzapine equivalent dose.